Brain penetrant, humanized, IgG4 monoclonal antibody
Intraveinous route of administration - monthly administration
Priority indication: Amyotrophic Lateral Sclerosis (ALS)
To be broaden to Parkinson's, Alzheimer's, Multiple Sclerosis
Achieved:
Subcutaneous route of administration - weekly administration
Achieved: